About this trial
This study, set up as a cross-sectional survey, seeks to delve into the disease burden and the demographic specifics of lower urinary tract symptoms (LUTS) among the male community in China. The investigators's main aim is to map out the overall and age-specific prevalence rates of LUTS within the Chinese male population. These insights are critical for understanding the public health dimensions of this condition. Moreover, the investigators plan to investigate several secondary aspects: the correlation of LUTS prevalence with factors like urbanization levels (rural vs. urban), geographical distribution, and lifestyle choices. Another significant focus will involve examining the treatment landscape for LUTS, looking at the portion of sufferers receiving treatment, the diversity in treatment durations, and the types of treatments employed (medication vs. surgery). This comprehensive analysis is intended to shed light on the prevailing management strategies for LUTS in China. The study is scheduled to unfold over 36 months and will comprise three pivotal phases: initial preparations, recruitment of subjects and collection of data, followed by the analysis of data and compilation of reports. The investigators will employ a range of methods such as questionnaires, physical exams, laboratory tests, imaging, and other medical evaluations to amass extensive data. This will allow the investigators to evaluate the prevalence of LUTS across various age groups among men and address the current gaps in epidemiological understanding.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Mainland China, aged 40 or older, male, in 31 provincial-level administrative regions.
Have resided for a total of 6 months or more in the survey county (district) in the past 12 months.
Normal communication, cooperation during physical examination, and good cognitive ability.
Willing to participate in and cooperate with this study, and sign the informed consent form.
Disqualifiers
Closed communities, such as armed forces and nursing homes.
Individuals with mental illnesses or other conditions that prevent cooperation.
Trial population
community sample
Trial design
Ecologic or community
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
International Prostate Symptom Score(IPSS)
A questionnaire to assess the condition of the prostate, report by score.The minimum value is 0, the maximum is 35, and the larger the score, the more severe the symptoms.
Overactive Bladder Syndrome Score(OABSS)
A questionnaire to assess the condition of overactive bladder, report by score.The minimum value is 0, the maximum is 15, and the larger the score, the more severe the symptoms.The minimum value is 0, the maximum is 15, and the larger the score, the more severe the symptoms.
International Consultation on Incontinence Questionnaire - Short Form(ICIQ-SF)
Detection through urinary flow rate meter, report by score.The minimum value is 0, the maximum is 11, and the larger the score, the more severe the symptoms
Quality of Life Score(QOL)
t was used to assess the impact of lower urinary tract symptoms on quality of life, with a minimum score of 0 and a maximum score of 6. The smaller the score, the higher the quality of life.
Secondary outcomes
Prostatic volume
By transabdominal ultrasound, Prostatic volume (ml)= Lateral diameter of prostate(cm)\* Anterior and posterior prostatic diameter(cm) \* Diameter superior and inferior prostatic (cm) \*0.52
Maximum urinary flow rate
Detection through urinary flow rate meter (ml/min)
Residual urine
By transabdominal ultrasound (ml)
free prostatic specific antigen(fPSA)
ng/ml
Sponsors and contacts
Click on the lead sponsor to view all of their trials.